Product
Caffeine
Aliases
Caffeine 200 mg, Caffeine Tablet
24 clinical trials
27 indications
Indication
HIV InfectionsIndication
HealthyIndication
CirrhosisIndication
Postoperative Dental PainIndication
CancerIndication
ObesityIndication
Rheumatoid ArthritisIndication
COVID-19Indication
Healthy Control ParticipantsIndication
AnalgesicIndication
Acute ExerciseIndication
Caffeine WithdrawalIndication
Memory DeficitsIndication
Adult PopulationIndication
Spinal Cord InjuriesIndication
Healthy ParticipantsIndication
Adolescent Idiopathic ScoliosisIndication
Intermittent HypoxiaIndication
Oxygen ToxicityIndication
HypercapniaIndication
SeizureIndication
CaffeineIndication
Sleep DeprivationIndication
Female Sexual Arousal DisorderIndication
Food-drug InteractionIndication
Preterm InfantIndication
CannabinoidsClinical trial
Effects of GSK3640254 on the Single-Dose Pharmacokinetics of Probe Substrates (Caffeine, Metoprolol, Montelukast, Flurbiprofen, Omeprazole, Midazolam, Digoxin, and Pravastatin) in Healthy SubjectsStatus: Completed, Estimated PCD: 2021-03-10
Clinical trial
A Phase I, Open-label, Fixed-sequence, Drug Interaction Study to Investigate the Effect of Multiple Oral Doses of LOXO-305 on CYP1A2, CYP2C9, and CYP2C19 Substrates Using a Probe Drug Cocktail in Healthy SubjectsStatus: Completed, Estimated PCD: 2021-04-15
Clinical trial
Profiling Study for the Hepatic Cytochrome P450 (CYP) Isozymes CYP1A2, CYP2C9, CYP2C19, CYP2D6 and CYP3A in Healthy Subjects and in Patients With Stage 4 (F4) Liver Fibrosis / Cirrhosis by the Combined Administration of the Probe Substrates (the Cocktail) Caffeine, Warfarin, Omeprazole, Metoprolol, and MidazolamStatus: Recruiting, Estimated PCD: 2025-01-14
Clinical trial
A Randomized, Double-Blind, Single-Dose, Parallel, Placebo-Controlled Pivotal Trial to Confirm the Efficacy of a Fixed Dose Combination Tablet of Naproxen Sodium and Caffeine to Effectively Alleviate Postsurgical Dental PainStatus: Completed, Estimated PCD: 2024-01-25
Clinical trial
A Multiple-Dose Drug-Drug Interaction Study to Determine the Effect of LY3437943 on Drug Metabolizing EnzymesStatus: Completed, Estimated PCD: 2023-02-24
Clinical trial
A Phase 1, Open-label, Multiple-probe Drug-drug Interaction Study to Determine the Effect of Rucaparib on Pharmacokinetics of Caffeine, S-Warfarin, Omeprazole, Midazolam, and Digoxin in Patients With Advanced Solid TumorsStatus: Completed, Estimated PCD: 2017-03-01
Clinical trial
A Phase 1, Open-label, Study in Subjects With Rheumatoid Arthritis to Evaluate the Effect of a Single Dose of Olokizumab on the Pharmacokinetics of Substrates for CYP1A2, CYP2C9, CYP2C19, and CYP3A4Status: Completed, Estimated PCD: 2022-06-08
Clinical trial
A NON-RANDOMIZED, MULTIPLE-DOSE, OPEN-LABEL, SINGLE SEQUENCE STUDY TO EVALUATE THE EFFECT OF CONCOMITANT ADMINISTRATION OF EDP-235 ON THE PHARMACOKINETICS AND SAFETY OF MIDAZOLAM, CAFFEINE, AND ROSUVASTATIN IN HEALTHY PARTICIPANTSStatus: Completed, Estimated PCD: 2022-11-04
Clinical trial
A Phase 1, Single-center, Open-label, Sequential Study to Evaluate the Drug-drug Interaction Potential of BMS-986196 in Healthy ParticipantsStatus: Completed, Estimated PCD: 2023-08-24
Clinical trial
A Phase 1 Open-label Study to Assess the Effect of BMS-986419 on the Single Dose Pharmacokinetics of Probe Substrates (Caffeine, Bupropion, Flurbiprofen, Omeprazole, Midazolam, and Fexofenadine) in Healthy ParticipantsStatus: Completed, Estimated PCD: 2023-09-13
Clinical trial
The Mechanism of Human Non-Shivering Thermogenesis and Basal Metabolic RateStatus: Recruiting, Estimated PCD: 2025-02-02
Clinical trial
Comparative Study Between Analgesic Effect of Oral Prednisolone and Oral Pregabalin in Management of Post-dural Puncture Headache in Patients Undergoing Lower Limb SurgeriesStatus: Completed, Estimated PCD: 2023-08-30
Clinical trial
Comparing the Acute Effects of Exercise and Caffeine on Working Memory During a Short Period of Caffeine Deprivation in Moderate to Heavy Caffeine ConsumersStatus: Completed, Estimated PCD: 2022-03-31
Clinical trial
The Acute Effects of Moderate Intensity Exercise and Caffeine Ingestion on Cognition in Non-Caffeine Consumers and Caffeine ConsumersStatus: Completed, Estimated PCD: 2019-06-01
Clinical trial
The Effects of Intermittent Hypoxia on Leg Function in Human Spinal Cord Injury (Caffeine Substudy)Status: Completed, Estimated PCD: 2021-03-19
Clinical trial
A PHASE 1, OPEN-LABEL, FIXED-SEQUENCE, 2-PERIOD STUDY TO ESTIMATE THE EFFECT OF MULTIPLE DOSE ABROCITINIB ON THE PHARMACOKINETICS OF SINGLE DOSES OF CAFFEINE, EFAVIRENZ, AND OMEPRAZOLE IN HEALTHY PARTICIPANTSStatus: Completed, Estimated PCD: 2022-02-26
Clinical trial
Oral Caffeine Decreases the Frequency of Opioid Demand in AIS Patients After Spinal FusionStatus: Recruiting, Estimated PCD: 2024-11-01
Clinical trial
Intermittent Hypoxia and Caffeine in Infants Born Preterm (ICAF)Status: Completed, Estimated PCD: 2023-06-01
Clinical trial
Applied Physiology of Oxygen Toxicity: Mechanisms in HumansStatus: Recruiting, Estimated PCD: 2026-03-01
Clinical trial
Consequences of Caffeine Intake in Teenagers: Effects on Sleep, Reward Processing, Risk Taking, and Underlying Cerebral Mechanisms Under Conditions of Sleep RestrictionStatus: Recruiting, Estimated PCD: 2024-09-01
Clinical trial
Examining Caffeine as a Treatment for Antidepressant-induced Arousal Dysfunction in WomenStatus: Completed, Estimated PCD: 2023-04-15
Clinical trial
Licorice Botanical Dietary Supplements - Metabolism and Safety in WomenStatus: Completed, Estimated PCD: 2020-07-31
Clinical trial
Baby-CINO: CaffeINe Treatment Optimisation in Premature InfantsStatus: Recruiting, Estimated PCD: 2024-09-01
Clinical trial
A Double-Blind, Randomized, Placebo-Controlled, Within-Subject Crossover Study of the Effects of Combinations of Cannabinoids and CaffeineStatus: Recruiting, Estimated PCD: 2024-07-01